MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (Q65465366)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors |
clinical trial |
Statements
A Phase II Study of MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors (English)
0 references
12 September 2016
0 references
21 September 2017
0 references
4
0 references
18 year
0 references